BioLineRx (BLRX) Cash from Operations (2010 - 2026)
BioLineRx (BLRX) recorded Cash from Operations of -$3.22 million in the quarter ended Jun 30, 2026, compared with -$177,000 a year earlier.
Powered by 
Analysis
BioLineRx (BLRX) Cash from Operations (2010 - 2026) Analysis & Trends
On a TTM basis, BioLineRx's Cash from Operations came in at -$10.8 million as of Jun 30, 2026; for the year ended Dec 31, 2025, it came in at -$8.07 million.
- Across earlier years, Cash from Operations came in at -$43.87 million in the year ended Dec 31, 2024, -$22.61 million in the year ended Dec 31, 2023, -$26.24 million in the year ended Dec 31, 2022 and -$23.57 million in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Cash from Operations since the quarter ended Dec 31, 2024.
- Per Business Quant, the preceding three quarters came in at -$2.28 million (quarter ended Mar 31, 2026), -$3.2 million (quarter ended Dec 31, 2025) and -$2.11 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 10.69 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 7.72 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 3.44 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 5.37 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 5.88 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 2.87 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 4.00 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.57 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 835.00 Mn |
| 10 | BioLineRx | 8.53 Mn | -67.99 Mn | 235,000.00 | -3.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.22 Mn |
| Mar 31, 2026 | -2.28 Mn |
| Dec 31, 2025 | -3.20 Mn |
| Sep 30, 2025 | -2.11 Mn |
| Jun 30, 2025 | -177,000.00 |
| Mar 31, 2025 | -2.59 Mn |
| Dec 31, 2024 | -8.61 Mn |
| Sep 30, 2024 | -9.83 Mn |
| Jun 30, 2024 | -11.33 Mn |
| Mar 31, 2024 | -14.11 Mn |
| Dec 31, 2023 | 4.99 Mn |
| Sep 30, 2023 | -9.90 Mn |
| Jun 30, 2023 | -9.68 Mn |
| Mar 31, 2023 | -8.02 Mn |
| Dec 31, 2022 | -5.68 Mn |
| Sep 30, 2022 | -8.68 Mn |
| Jun 30, 2022 | -6.29 Mn |
| Mar 31, 2022 | -5.59 Mn |
| Dec 31, 2021 | -5.50 Mn |
| Sep 30, 2021 | -5.01 Mn |
API Access
BioLineRx Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();